U.S. Supreme Court slaps big pharma for paying generic makers to delay lower cost medications
Ruled 5-3 that agreements between the makers of name-brand and generic drugs to delay the generics' availability can be illegal, an outcome cheered by consumer groups.
LATEST NEW HAMPSHIRE ANGLE
Judge dismisses convicted killer’s claim that former defense had improper relations with Ayotte
Keystone split: Shaheen got $650K from interests opposed, Ayotte received $400K from energy lobby
Bobcat resurgence raises trapping talk
Mark Hayward's City Matters: Manchester man gets his stolen Cadillac back along with a $125 tow bill
Granite State volunteers honor MLK's legacy